Antibacterial Agent Screening
Antibacterial Agent Screening - Related Videos
06:41
A Peg Plate Biofilm Assay for Screening Antibacterial Agents
0 Views •
2025
This video demonstrates an assay for screening antimicrobial compounds that efficiently eliminate biofilms using a peg-plate. The methodology monitors the biofilm's metabolic state after treatment with antimicrobial compounds, facilitating the determination of the minimum biofilm eradication concentration.
09:17
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
0 Views •
Cited by 17 •
2017
A method for establishing lung infections in immunocompetent rodents is described. With proficiency, this method can be performed quickly and easily to induce stable infection with many isolates of S. pneumoniae, H. influenzae, P. aeruginosa, K. pneumoniae and A. baumannii.
02:19
Determining the Antibacterial Efficacy of an Antibiotic-Loaded Polymeric Strip
0 Views •
2025
Source: Sekar, A., et. al., A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials. J. Vis. Exp. (2023)This video demonstrates a luminescence-based assay for assessing the antibacterial efficacy of an antibiotic-loaded polymeric strip by quantifying ATP-driven luminescence, which decreases in bacterial cultures exposed to the antibiotic.
05:57
Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
0 Views •
2024
Fission yeast is used here as a heterologous host to express bacterial cytoskeletal proteins such as FtsZ and MreB as translational fusion proteins with GFP to visualize their polymerization. Also, compounds that affect polymerization are identified by imaging using a fluorescence microscope.
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
FAQs
A useful screening distinction is whether a candidate merely inhibits bacterial growth or reduces cell viability. Growth-based measurements show that multiplication has been suppressed, whereas viability measurements indicate whether cells remain alive. Comparing these outcomes helps characterize an agent’s effect and supports more precise interpretation of antibacterial activity.
Genetic assays connect a bacterial response with genomic features such as mutations, resistance genes, or affected cellular pathways. When a candidate changes growth, viability, or susceptibility, researchers can examine these features to determine which genetic differences accompany the response. This genotype-phenotype comparison helps explain why related bacteria may respond differently to the same agent.
Resistance evolution is examined by pairing antibacterial responses with genetic information rather than treating susceptibility as a fixed trait. Mutations and resistance genes can be associated with reduced activity or changed susceptibility, while pathway analysis can indicate how bacterial biology influences the response. This approach helps connect genomic change with phenotypic resistance.
A basic workflow exposes bacterial cultures to candidate chemical compounds or biological products under controlled conditions. Researchers then measure outcomes such as growth inhibition, cell viability, or changes in susceptibility. Genetic assays may follow these measurements to associate response differences with mutations, resistance genes, or cellular pathways, creating a combined phenotypic and genetic profile.
Each measurement describes a different aspect of the bacterial response. Growth inhibition indicates that multiplication has been limited, viability measurements address whether cells remain alive, and susceptibility changes show how responsive bacteria are to an agent. Considering these outcomes together provides a fuller characterization than relying on a single screening measurement.
In genetics research, screening supports experiments that connect bacterial genotype with phenotype, including responses associated with mutations, resistance genes, and cellular pathways. More broadly, the results can identify leads for antimicrobial discovery and contribute to resistance surveillance. They also provide a framework for studying how bacterial genomes influence drug sensitivity and resistance evolution.